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Nanoparticle-mediated photothermal therapy (NP-PTT) constitutes a flexible, highly selective, 
cost effective and accurate tool for cancer treatment alone or in combination with other 
therapies such as radiotherapy or chemotherapy. The future application of NP-PTT in real life 
mainly depends on the design and synthesis of novel multifunctional nanoparticles that could 
overcome the current limitations of NP-PTT such as limited penetration depth and absence of 
therapy control. In this work we report on ultrasmall (~2.4 nm) NdVO4 stoichiometric (100 % 
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constituent Nd3+ ions) nanoparticles capable, under 808 nm optical excitation, of in vivo sub-
tissue localized heating while providing, simultaneously,  the possibility of high penetration 
near-infrared fluorescence imaging. Ultrasmall NdVO4 stoichiometric nanoparticles have 
evidenced a superior light-to-heat conversion efficiency. This is explained in terms of their 
large absorption cross section at 808 nm (consequence of the particular spectroscopic 
properties of neodymium ions in NdVO4 and of the high neodymium content) as well as to 
their ultrasmall size that leads to large non-radiative decay rates. Results included in this work 
introduce to the scientific community ultrasmall NdVO4 stoichiometric nanoparticles as 
multifunctional photothermal agents that could be considered as an alternative to traditional 
systems such as metallic, organic or carbon-based nanoparticles. 
 
1. Introduction 
Thermal therapy, which relies on heat as a means to cause cell death, has been widely 
explored in the past as a minimally invasive tool to treat different diseases, including 
malignant tumors.[1] In order to maximize the efficacy of the therapy and to simultaneously 
minimize the undesirable collateral damage, the tumor must be heated up to cytotoxic levels 
while keeping the heating at the surroundings at a minimum.[2] Such selectivity has been 
achieved by using photothermal nanoparticles (PT-NPs), capable of efficient heat generation 
under optical excitation. Nanoparticle-assisted photothermal therapy (NP-PTT) consists on 
the selective incorporation of heating NPs inside the tumor to be treated in such a way that a 
subsequent optical excitation would produce a well localized heating of the tumor. NP-PTTs 
have already been used for in vivo cancer treatment in animal models with remarkable 
success.[3] Although a great variety of nanostructures, ranging from gold NPs to carbon-based 
nanomaterials and even organic NPs, have been used as photothermal agents, the research on 
novel heating NPs capable of overcoming the actual limitations of NP-PTT is a hot area 
involving a large scientific community.[4] One of the most important limitations of 
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photothermal therapy is the light absorption and scattering of biological tissues, which results 
in a reduced penetration depth of the optical excitation radiation required for sub-tissue heat 
generation.[5] This limitation can be partially overcome by working with heating NPs with 
high absorption cross sections at wavelengths lying in the so-called biological windows 
(BWs). These BWs correspond to spectral ranges (700-900 nm, first BW, 1000-1400 nm, 
second BW and 1500-1800 nm, third BW) where tissues are partially transparent due to the 
simultaneous reduction of both absorption and scattering coefficients.[6] Besides allowing for 
a better penetration depth, working in the BWs also minimizes the light-induced damage in 
healthy tissues, as the optical excitation radiation will not be significantly absorbed by tissues, 
so that the energy deposition will be kept at a minimum.[7] 
Rare earth-doped nanoparticles (RENPs), initially used as simple optical markers,[8] have 
been explored in the past few years as PT-NPs concluding that they could constitute a reliable 
alternative to the widely used metallic and carbon nanostructures.[9]  In most of the cases, 
light-induced heating in RENPs is accompanied by the simultaneous generation of a 
fluorescence signal especially suitable for in vivo imaging.[10] This would be particularly 
interesting when analyzing the outcome of a photothermal therapy, as fluorescence imaging 
could be used to monitor the post-treatment evolution of the tumor. Furthermore, RENP 
fluorescence would also provide the possibility of tracking them in real time after thermal 
treatment, thus allowing to determine their biodistribution and clearance from the body.[11] In 
this context, neodymium (Nd3+) arises as a most interesting doping ion for this type of NPs. 
First of all, Nd3+ ions can be efficiently excited by 808 nm radiation, which lies in the first 
biological window and is produced by cost-effective laser diodes. This excitation wavelength 
has also been demonstrated to be a “safe” wavelength in biological applications.[12] Moreover, 
Nd3+ ions characteristic emission bands (at around 890, 1060 and 1350 nm) all lie in the 
biological windows, which allow for deep-tissue imaging using an infrared camera.[13] 
Previous works have demonstrated high light-to-heat conversion efficiencies in heavily-doped 
  
4 
 
Nd3+-doped RENPs (Nd:NPs) as a consequence of an enhancement in the absorption cross 
section together with a reduction in the fluorescence quantum yield (QY), respectively.[14] Up 
to now, different neodymium-doped fluoride nanocrystals with varying Nd3+ content have 
been studied for NP-PTT.[15] In particular, heavily-doped (5.6 at.%) Nd:LaF3 NPs have been 
successfully used for self-monitored temperature controlled photothermal therapy.[16]  
Previous studies have concluded that, while Nd:NPs display the already mentioned 
interesting properties (such as superior spectral and physical stabilities), they also present the 
disadvantage of a relatively low absorption cross section per NP, which results in a non-
efficient absorption of optical excitation radiation.[3] Such reduced absorption cross section 
stems from the intrinsic low absorption probabilities characteristic of Nd3+ ions as well as 
from the typically low content of Nd3+ ions per RENP (usually below 10 mol.%). This 
limitation can be partially overcome by increasing the doping level, i.e., the content of rare 
earth ions per NP, as it would lead to an overall increase in the RENPs absorption cross 
section. Nevertheless, massive incorporation of Nd3+ ions in NPs is not an easy task as it 
typically causes a remarkable deterioration in the structural properties of Nd:NPs. Still, it is 
possible to find in the literature numerous examples of crystalline materials in which a 
complete substitution of constituent ions by Nd3+ ions is possible, leading to the so-called 
stoichiometric crystals (with a 100% mol. concentration of Nd3+ ions). Among all the Nd3+ 
doped stoichiometric systems reported up to now, neodymium orthovanadate (NdVO4) seems 
to be particularly interesting. Neodymium-doped orthovanadate crystals show excellent 
mechanical and physical properties that are accompanied by an outstanding optical absorption 
at 808 nm, an especially desirable wavelength for biomedical applications, as explained 
above.[17] Despite their good bulk properties the potential application of NdVO4 stoichiometric 
nanoparticles as PTT-NPs is still unexplored.     
In this work, we have synthesized ultrasmall NdVO4 stoichiometric NPs. Their infrared 
spectroscopic properties as well as their light-to-heat conversion capability have been 
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thoroughly investigated and results have been compared to those obtained for other Nd3+ 
doped PT-NPs. Ex vivo and in vivo experiments were conducted in order to corroborate their 
potential application of ultrasmall NdVO4 stoichiometric NPs as multifunctional photothermal 
agents and imaging probes.   
 
2. Results and discussion 
2.1. Synthesis and characterization of NdVO4 ultrasmall NPs 
The ultrasmall NdVO4 stoichiometric NPs used in this work were synthesized for the first 
time using the colloidal (citrate) synthetic route described in detail in the Experimental 
section. Although the fabrication of NdVO4 NPs has already been reported, other synthesis 
procedures, such as sonochemical or (solvo-)hydrothermal were used, resulting in NPs with 
average sizes much larger than the ones presented in this work.[18]  Inset in Figure 1(a) shows 
a characteristic high resolution STEM image of a representative group of NdVO4 
stoichiometric NPs. The statistical analysis of different STEM images, some of which are 
included in the Supporting Information (section S1) allowed us to build up the size histogram 
displayed in Figure 1(a) from which an average NP size of ~2.4 nm was determined. The 
crystalline character of the NPs was confirmed by X-Ray Diffraction (XRD), as is shown in 
section S2 of the Supporting Information. 
Ultrasmall NPs, with sizes below 10 nm, have been reported to have significant advantages 
with respect to larger NPs for biological applications. In particular, they show better 
penetration into cells and are even able to penetrate the nuclear membrane, as demonstrated 
by in vitro experiments. Indeed, upon intravenous injection in mice with tumors, smaller NPs 
show longer blood circulation half-lives and much higher uptake by the tumors.[19] In our 
case, the ultrasmall size of NPs is accompanied by an outstanding colloidal character and 
remarkable stability, as no sign of precipitation or degradation was observed in the samples 
after months of storage. Aqueous dispersions of NdVO4 stoichiometric NPs with 
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concentrations as high as 10% in mass were prepared without any sign of precipitation for 
months. Figure 1(b) includes, as an example, an optical image of an aqueous dispersion of 
NdVO4 stoichiometric NPs. Contrary to the colorless appearance of aqueous dispersions of 
other neodymium-doped NPs,[14] the NdVO4 colloidal dispersion presents an evident blue 
color. This reveals, simultaneously, a strong absorption in the visible (caused by the large 
Nd3+ content per NPs) and a negligible optical scattering (thanks to their reduced size and the 
absence of particle agglomeration, which is demonstrated in the DLS results shown in the 
Supporting Information, section S3). The superior optical absorption of NdVO4 stoichiometric 
NPs when compared to previously used Nd3+-doped PT-NPs is evidenced in Figure 1(b) that 
includes, for the sake of comparison, the absorption spectrum of an aqueous solution of 
Nd:LaF3 NPs at a concentration of 10% in mass. The neodymium concentration in Nd:LaF3 
NPs was set to 5.6 at.%, being this the maximum neodymium content that could be 
incorporated without compromising their morphological quality or their colloidal stability 
(this is why 5.6 at.% doped Nd:LaF3 NPs were considered in previous works as  
“heavily-doped” NPs). As can be observed, the absorption of our NdVO4 NPs is markedly 
larger than that of the heavily-doped Nd:LaF3 NPs that have been successfully used as 
photothermal agents.[16] From the absorption spectrum included in Figure 1(c) we have 
estimated a peak absorption cross section per NP mass close to 75 cm2·g-1 for the NdVO4 
stoichiometric NPs. This is, roughly, 20 times that estimated for the previously used Nd:LaF3 
PT-NPs (close to 3.8 cm2·g-1 for a neodymium concentration of 5.6 at.%) that cannot be 
solely explained by the different neodymium concentration (about 4 times higher in NdVO4 
stoichiometric NPs than in Nd:LaF3 NPs). The difference in the absorption coefficients could 
be also attributed the different absorption cross sections of neodymium ions in both crystal 
matrices. Although these values are not known for either LaF3 or NdVO4 NPs, we can 
estimate it from previous works dealing with neodymium-doped LaF3 and NdVO4 crystals.  
The absorption cross section at  790 nm of neodymium ions in LaF3 crystals has been found 
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to be close to 2.5·10-20 cm2 whereas the unpolarized absorption cross section at  808 nm of 
neodymium ions in (Gd,Y)VO4 crystals is close to 20·10
-20 cm2.[20] Thus the absorption cross 
section of neodymium ions in NdVO4 NPs can be assumed to several times larger than in 
LaF3 NPs, this difference also contributing to the much larger absorption coefficient per mass 
found for NdVO4 NPs.  
 
2.1.1. Spectroscopic characterization 
 
In addition to their larger absorption, NdVO4 NPs present an additional advantage with 
respect to their Nd:LaF3 counterparts. The absorption peak wavelength of ultrasmall NdVO4 
NPs lies at 808 nm, where commercial cost effective diodes typically operate.  This is at 
variance to the case of Nd:LaF3 NPs for which the position of their absorption peak (789 nm) 
requires the use of specially pre-designed laser diodes. The comparison included in Figure 
1(c) suggest that ultrasmall NdVO4 NPs would require much lower 808 nm laser power 
densities to achieve the same heating effects than Nd:LaF3. 
The high neodymium content in NdVO4 stoichiometric NPs, which results in an extremely 
high absorption cross section, also affects their luminescence properties. Heavily-doped NPs 
typically produce much lower fluorescence signals than NPs with lower contents of 
neodymium ions, due to the well-known emission concentration quenching. Despite their 
extremely high neodymium content, the NdVO4 NPs still present a bright fluorescence signal, 
as is evidenced in the inset of Figure 2(a) that shows the infrared (900-1700 nm) image of a 
colloidal suspension of NdVO4 NPs (0.6% mass concentration). The emission spectrum 
obtained under 808 nm optical excitation is shown in Figure 2(a), where the three emission 
bands characteristic of Nd3+ ions at around 890, 1060 and 1300 nm (corresponding to 
transitions 4I9/2 → 4F3/2, 4I11/2 → 4F3/2 and 4I13/2 → 4F3/2, respectively) can be clearly seen. As 
we mentioned before, all these bands lie in the biological windows, making these NPs 
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particularly suitable for deep-tissue fluorescence bioimaging. [10, 15c, 21] Figure 2(b) includes 
the fluorescence decay curve of the colloidal solution of NdVO4 NPs as obtained under 808 
nm, 10 ns optical pulsed excitation.  The decay curve was found to follow a single 
exponential decay with a fluorescence lifetime value as low as 150 ns. Both the single 
exponential character and the reduced fluorescence lifetime value can be explained by taking 
into account different factors. First of all, the ultrasmall size of NdVO4 NPs results in a very 
high surface to volume ratio, which means that a large (over 80%) proportion of Nd3+ atoms 
in a single NdVO4 NP will be in the surface so that nonradiative interactions with the aqueous 
medium will dominate over radiative transitions. 
In general, as has been demonstrated for other RENPs, smaller NP sizes result in lower QYs 
and therefore, in shorter lifetime values.[22] Moreover, the high neodymium content, which 
confers these NPs their photothermal properties, also contributes to a shortening of the 
fluorescence lifetime by promoting energy migration to surface ions as well as Nd3+-Nd3+ 
cross relaxation nonradiative decay processes.[23] The contribution of such processes to the 
drastic reduction in the fluorescence lifetime found for our NdVO4 stoichiometric NPs has 
been investigated by measuring the fluorescence decay curves of Nd3+-doped GdVO4 
ultrasmall NPs with different doping levels. Results are included in Figure 2(b).  A continuous 
decrease of the fluorescence lifetime with increasing Nd3+ content has been observed. 
Fluorescence lifetimes were found to be 500, 300 and 150 ns for Nd3+ molar doping levels of 
6, 18 and 100%, respectively. The fluorescence lifetime previously reported for a 1 at.% Nd3+ 
(6 mol.%) doped GdVO4 bulk crystal was close to 80 µs,28 i.e. close to 160 times the 
fluorescence lifetime obtained for GdVO4 ultrasmall NPs with the same doping level. This 
reduction is unequivocally related to the large surface-to-volume ratio characteristic of NPs 
and it does not obey to Nd3+-Nd3+ interactions that are assumed to be present in both bulk and 
nanosized crystals. On the other hand, increasing the Nd3+ doping level from 6 up to 100 
mol.% causes an additional four fold reduction in the fluorescence lifetime. We can, therefore, 
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conclude that the main cause of the short fluorescence lifetimes found for ultrasmall NdVO4 
NPs is the nonradiative decay taking place at the NPs surface.[24] 
In order to estimate the contribution of the nonradiative decay to the light-to-heat conversion, 
we calculated the photothermal conversion efficiency, η, of our NPs as is described in detail 
in section S2 of the Supporting Information. The photothermal conversion efficiency, defined 
as the fraction of the absorbed power that is transformed into heat, has been calculated by 
monitoring the temperature during a cycle of laser-induced heating and subsequent cooling of 
an aqueous dispersion of NPs using expression (1), as is described in the literature.[25] 
(1)   
where h is the heat transfer coefficient and A, the surface area of the container where the 
solution is placed, while Tmax and T0 represent the maximum temperature reached by the 
dispersion containing the NPs and the temperature at the surroundings, respectively. Q0 
corresponds to the heat dissipated from the light absorbed by the solvent and container, I to 
the laser power and OD to the optical density of the sample. Using the procedure found in the 
literature and described in section S4, we found a photothermal conversion efficiency η = 
72.1 % at an excitation wavelength of 808 nm. This is among the highest photothermal 
conversion efficiencies reported for nanosized photothermal agents, as is evidenced in Table 
S1 in the Supporting Information. 
We also investigated the wavelength dependence of the laser-induced heating of an aqueous 
suspension of NdVO4 NPs under optical excitation by a 780-830 nm tunable Ti:Sapphire laser. 
For each wavelength a thermographic image of the colloidal solution was recorded. The 
obtained results are summarized in Figure 3, where three representative thermographic 
images obtained upon laser excitation at 790, 808 and 820 nm, respectively, are shown 
(Figure 3(a)). Figure 3(b), in which the maximum steady state temperature increment is 
represented as a function of the irradiation wavelength, reveals that the maximum heating 
occurs at 808 nm, in good accordance with the position of the absorption peak (see Figure 
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1(c)). Indeed, the heating spectrum included in Figure 3(b) well reproduces the spectral shape 
of the absorption spectrum of NdVO4 NPs. This unequivocally indicates that the light-to-heat 
conversion efficiency of the colloidal dispersion is governed by the optical absorption of 
NdVO4 NPs. 
In order to compare the heating efficiency of our NdVO4 stoichiometric NPs with their 
Nd:LaF3 PT-NPs counterparts, we analyzed their heating performance in ex vivo experiments. 
A chicken breast tissue sample was injected at 2 mm depth with 100 µL of an aqueous 
dispersion of NdVO4 NPs at a mass concentration of 10%. The tissue was then irradiated with 
different 808 nm laser intensities and thermographic images, such as the ones shown in 
Figure 4(a), were collected in order to determine the light-induced temperature increment at 
the tissue surface. Results are included in Figure 4(b). The tissue temperature increases 
linearly with the laser intensity, with a slope close to 12 ºC·cm2·W-1. For the sake of 
comparison, the temperature vs laser power slopes obtained in the past by using heavily-
doped (5.6% at.) Nd:LaF3 NPs under similar conditions have also been schematically  
included in Fig. 4(b).[26] At this point it should be noted that, although the same diode laser 
was used in both cases, for experiments involving the Nd:LaF3 NPs the diode wavelength was 
temperature tuned down to 802 nm in order to increase the optical absorption of Nd:LaF3 NPs 
(whose absorption spectrum peaks at 790 nm).[27]  As we mentioned before, Nd:LaF3 NPs 
have been successfully used as therapeutic photothermal agents, however, their heating curve 
has a less pronounced slope (below 5 ºC·cm2·W-1).[15a, 16] It is important to note that the 
heating efficiency of Nd:LaF3 NPs would be about 80% higher if the excitation wavelength 
matched the absorption peak (≈ 789 nm).[16] However, even after wavelength optimization, 
the heating efficiency of Nd:LaF3 would still be lower than that of NdVO4 NPs. This could be 
explained in terms of the larger absorption cross section of the NdVO4 NPs, as has been 
previously discussed, and also in terms of a larger the fractional thermal loading (fraction of 
the absorbed energy that is converted into heat) of NdVO4 NPs, which is known to increase 
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with neodymium concentration in a nonlinear way.[16] At this point, we should note that the 
fact that the optimum excitation wavelength of NdVO4 NPs is 808 nm instead of 790 nm is an 
additional advantage, as 790 nm radiation has been demonstrated to be much more harmful to 
cells than 808 nm radiation.[12] 
The superior heating efficiency of ultrasmall NdVO4 stoichiometric NPs indicates that using 
them as photothermal agents for tumor treatments would substantially reduce the optical 
excitation densities required for efficient treatment when compared to previously used 
neodymium-doped PT-NPs. This, in turn, would lead to a significant reduction in the 
magnitude and extension of the undesirable collateral damage. 
The potential ability of ultrasmall NdVO4 stoichiometric NPs for simultaneous laser-
induced heating and imaging was finally tested in an animal model (in vivo). For that purpose, 
a CD1 mouse was subcutaneously injected with 100 µL of a concentrated dispersion of 
NdVO4 NPs (10% mass concentration) in TBS (tris-buffered saline), corresponding to a total 
injected NP mass of 10 mg. Accurate localization of the subcutaneous injection of NdVO4 
NPs was achieved by measuring an infrared (> 1000 nm) fluorescence image of the mouse by 
using an InGaAs CCD camera. Optical excitation was performed with an 808 nm laser diode 
providing an excitation power density of 0.6 W·cm-2. Figure 5(a) shows an optical picture of 
the mouse in which the injection site is marked by an arrow. The infrared fluorescence image 
of the subcutaneously injected mouse is included in Figure 5(b), from which is clear that, 
even at this low laser power density, the injected NdVO4 NPs produce a bright fluorescence 
signal. The merge of both images is shown in Figure 5(c), in which the spatial overlap 
between the fluorescence signal and subcutaneous injection is evidenced. Figures 5(a)-(c) 
reveal the potential use of NdVO4 infrared fluorescence for subtissue imaging with moderate 
808 nm excitation densities, achievable with an inexpensive commercial laser diode. The 
same laser excitation intensity was applied to the mouse for 4 minutes while continuously 
monitoring the skin temperature with an infrared thermographic camera. The obtained results 
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are summarized in Figure 5. The time evolution of the surface temperature during a 4-minute 
long irradiation is represented in Figure 5(d), registering a skin temperature increment around 
17 ºC. Such laser-induced heating was found to be well localized at injection site as it is 
evidenced in the thermographic image included as an inset in Figure 5(d), which was 
recorded 4 minutes after starting the 808 nm laser irradiation.  
It has been demonstrated that during NP-PTT treatments the skin temperature does differ 
from that of the exact point where the injected volume is located. In particular, it has already 
been demonstrated that the difference between skin and injection site temperatures could be as 
high as 60 %.[15a] In our particular case, this means that even at lower 808 nm laser intensities  
the temperature at the injection site could reach temperatures of 50 ºC and higher, as required 
for tumor ablation.[28] It should be noted at this point that the 808 nm power density here used 
(0.6 W·cm-2) is well below the power densities previously used in photothermal therapies of 
cancer tumors also based on neodymium-doped NPs (typically above 1 W·cm-2) where a non-
negligible heating of non-targeted tissues was evidenced.[4b, 29] Indeed, such a low irradiation 
intensity is comparable to that previously used during the minimally invasive photothermal 
therapies of cancer tumors based on carbon nanostructures.[30] Consequently, ultrasmall 
NdVO4 stoichiometric nanoparticles emerge as a strong alternative to the traditionally used 
photothermal agents such as carbon based nanostructures and metallic nanoparticles.  
Although these results point out that NdVO4 nanoparticles are good candidates for in vivo 
photothermal therapy, before carrying out further experiments in animal models, a thorough 
evaluation of their toxicity needs to be performed.  While this is the case for any material 
intended for use in biomedicine, this is even more so the case with these NPs as NdVO4 
nanostructures have been reported to show photocatalytic activity, which would cause the 
production of free radicals upon illumination.[31] Despite this fact, the preliminary in vitro 
toxicity studies we have performed revealed no significant toxic effects for NP concentrations 
up to 500 µg/mL and incubation times as long as 6 hours, as can be seen in Figure 6. 
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However, further systematic and in depth in vitro studies need to be performed before 
definitely ruling out NP-associated toxicity. 
 
3. Conclusion 
In summary, we have demonstrated that the unique combination of optical properties of 
ultrasmall NdVO4 stoichiometric nanoparticles (808 nm centered absorption band, reduced 
QY yield –which implies a high heating capacity-, negligible scattering cross section) make 
them excellent candidates to be used as multifunctional  agents for in vivo photothermal 
cancer therapy. The results here presented prove the outstanding photothermal capabilities of 
the NdVO4 NPs, which suggest that they could be successfully used for selective in vivo 
photothermal therapy using very low laser intensities, although this fact needs to be 
completely evaluated in real photothermal therapy in tumor-bearing mice. Moreover, the 
bright luminescence signal presented by these NPs in the second biological window allows for 
easily determining the location of the NPs through infrared fluorescence imaging and could be 
applied to determine the NPs location after their injection and, also, to monitor the post-
treatment evolution of the tumor itself and the biodistribution and clearance of the NPs from 
the body.  
This work introduces to the scientific community rare earth-based stoichiometric NPs as 
promising and unexplored photothermal agents that could be a serious alternative to the 
traditionally used photothermal agents such as carbon-based materials and metallic NPs with 
the additional advantage of their deep-tissue imaging capabilities 
 4. Experimental Section  
Synthesis of colloidal NdVO4 nanoparticles. All chemicals: neodymium (III)-nitrate 
hexahydrate, Nd(NO3)3x6H2O (99.9%, Alfa Aesar), amonium-vanadium oxide, NH4VO3 (min. 
99.0%, Alfa Aesar), trisodium citrate (99+ %, Sigma Aldrich) and sodium-hydroxide, NaOH 
(min. 99%, Moss Hemos), were used without any purification. NdVO4 colloidal solutions 
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were synthesized by the following procedure: 0.05 M solution of trisodium citrate (15 mL) is 
added drop by drop to the 0.05M solution of Nd(NO3)3 (20 mL) at room temperature, and 
white precipitate from Nd3+- Cit3- complex was formed. After vigorous stirring for 30 min, 
white precipitate is completely dissolved by the addition, drop by drop, of 0.05 M NH4VO3 
(15 mL, dissolved in 0.15 M NaOH). The transparent and bluish solution, with pH of about 8, 
is subsequently heated and stirred at 60 °C for 60 min. Finally, the colloidal solution is cooled 
down to the room temperature. Slow growth of particles was achieved by dialysis against the 
water until pH = 7 of solution was reached.  
Electron microscopy characterization. The size of nanoparticles were studied by high-
resolution transmission electron microscopy with a Jeol ARM 200 CF, a probe Cs-corrected 
scanning transmission electron microscope, equipped with cold FEG electron source, operated 
at 200 kV. HAADF (High-angle annular dark-field) STEM (scanning transmission electron 
microscope) technique was used for sample imaging. 
Spectroscopic characterization. The absorption spectrum was measured using an 
UV/VIS/NIR spectrophotometer (Perkin Elmer Lambda1050). The emission spectrum was 
obtained under excitation with a tunable Ti:Sapphire (Spectra Physics 3900) laser working at 
808 nm. The luminescence signal was collected, after passing through appropriate filters, and 
spectrally analyzed by an infrared Germanium detector coupled to a SPEX 500M high-
resolution spectrometer. For the fluorescence lifetime measurements, a tunable pulsed optical 
parametric oscillator (Spectra Physics Quanta-Ray 730 MOPO) working at 808 nm was used 
as excitation source. The emission signal in that case was collected by a photomultiplier tube 
and recorded with a LeCroy digital oscilloscope. 
Fluorescence imaging. Fluorescence images were collected using an InGaAs CCD camera 
with enhanced sensitivity in the 1000-1700 nm spectral range (XEva1.7-320). Optical 
excitation was achieved using a fiber-coupled 808 nm laser diode (LIMO). A long pass filter 
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with cut-off wavelength at 850 nm was used to remove the 808 nm pump background. 
Thermal images were recorded using a thermographic camera (FLIR E40bx). 
Animal experiments. A 6-week-aged female CD1 mouse was subcutaneously injected with 
100 µL of a 10% in mass dispersion of the nanoparticles in PBS and subjected to irradiation 
with an 808 nm laser diode at 0.8 W·cm-2 for three minutes so as to perform an in vivo test of 
the photothermal properties of the NdVO4 NPs. All the experimental procedures with animals 
were carried out in compliance with the 2013/63/UE European guidelines and were approved 
by the Ethics Committee from Universidad Autónoma de Madrid (CEIT) in the frame of the 
project FIS- MAT2013-47395-C4-1-R supported by the Spanish Ministerio de Economía y 
Competitividad. 
In vitro cytotoxicity studies.The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide) assay is a simple non-radioactive colorimetric assay to measure cell cytotoxicity, 
proliferation or viability. MTT is a yellow, watersoluble, tetrazolium salt. Metabolically 
active cells are able to convert this dye into a waterinsoluble dark blue formazan by reductive 
cleavage of the tetrazolium ring. Formazan crystals, then, can be dissolved in an organic 
solvent such as dimethylsulphoxide (DMSO) and quantifed by measuring the absorbance of 
the solution at 540 nm, and the resultant value is related to the number of living cells. To 
determine cell cytotoxicity/viability, the cells were plated in a 24 well plate at 37 °C in 5% 
CO2 atmosphere. 
After 48 h of culture, the medium in the well was replaced with the fresh medium 
containing different concentrations of NdVO4 NPs (100, 200, 300, 400 and 500 μg/mL) and 
cells were incubated for 6 hours. After incubation, the medium was removed and added 
completed medium without nanoparticles. After 24 h, 0.5 mL of MTT dye solution (0.05 
mg/mL of MTT, Sigma) was added to each well. After 2–3 h of incubation at 37 °C and 5% 
CO2, the medium was removed and formazan crystals were solubilized in 0.5 mL of DMSO 
(Merck) and the solution was vigorously mixed to dissolve the reacted dye. The absorbance at 
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540 nm was read using a microplate reader (Espectra Fluor 4, Tecan). The% of viability of 
cells incubated with NPs as compared to control cells (i.e., without incubation with 
nanoparticles) was calculated as [A]test/[A]control ×100, where [A]test is the absorbance of the 
tested sample and [A]control is the absorbance of the control sample. 
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Figure 1. (a) Size histogram of the NdVO4 stoichiometric nanoparticles as obtained from the 
high resolution TEM included as an inset. (b) Optical picture of an aqueous dispersion of 
NdVO4 stoichiometric nanoparticles at a mass concentration of 0.6%. The blue color reveals a 
strong optical absorption in the visible due to Nd3+ ions. (c) Absorption spectrum of the 
colloidal dispersion shown in (b). The absorption spectrum of an aqueous dispersion of 
heavily-doped (5.6 at.%) Nd:LaF3 at the same concentration is included for comparison. 
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Figure 2. (a) Emission spectrum of a colloidal dispersion of NdVO4 (0.6 % mass 
concentration) obtained under optical excitation at 808 nm. The inset shows the infrared (900-
1700 nm) fluorescence image of the colloidal solution under 808 nm optical excitation as 
obtained with an InGaAs camera. (b) Fluorescence decay curve as obtained from a colloidal 
solution of NdVO4 nanoparticles. The decay curves obtained for 6 mol.% and 18 mol.% Nd
3+-
doped GdVO4 ultrasmall NPs have been included for comparison. 
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Figure 3. (a) Thermal images of a quartz cuvette containing a colloidal solution of NdVO4 at 
a 0.6 % mass concentration under optical excitation at three different wavelengths. (b) 
Maximum temperature increment produced in the colloidal solution as a function of the laser 
wavelength. A clear maximum is observed at 808 nm, in agreement with the peak position in 
the absorption spectrum. 
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Figure 4. (a) Thermal images of a subcutaneous injection (~2 mm depth) of NdVO4 
nanoparticles in chicken tissue as obtained for different 808 nm laser excitation intensities. 
Arrows indicate the location of the NdVO4 injection. (b) Maximum tissue surface temperature 
as a function of the 808 nm laser intensity. Dots are experimental data and dashed line is the 
best linear fit. The maximum tissue surface temperature obtained under the same experimental 
conditions with an injection of heavily-doped Nd:LaF3 (green line) and in the control case 
(blue line) are included for the sake of comparison. 
 
 
 
Figure 5. (a) Optical image of a CD1 mouse subcutaneously injected with 100 µL of an 
aqueous dispersion of NdVO4 stoichiometric NPs at (10% mass concentration). The arrow 
indicates the location of the injection.  (b) Infrared fluorescence image of the same mouse as 
in (a) as obtained under 808 nm, 0.2 W·cm-2 excitation with an AsGaIn camera before which 
a 1000 nm longpass filter was placed.  (c) Merge of (a) and (b) revealing fluorescence contrast 
only at the injection site. (d) Thermographic image of the mouse after 4 minutes under 
irradiation at 808 nm (0.6 W·cm-2). Note that the maximum heating corresponds to the 
injection site (e) Time evolution of the surface (skin) temperature at the injection site (black 
dots) and in a control mouse (blue dots) after switching on the 808 nm laser (0.6 W·cm-2). 
Dashed lines are guides for the eyes. 
 
 
 
  
22 
 
 
 
Figure 6. Fraction of surviving HeLa cells (%) after incubation for 6 hours with different 
concentrations of NdVO4 nanoparticles. Error bars correspond to the standard deviation. 
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IR-emitting NdVO4 ultrasmall NPs show a remarkable photothermal conversion efficiency 
(72.1%) under 808 nm irradiation, which makes them particularly interesting for combined 
photothermal therapy and bioimaging. Their outsanding light-to-heat conversion capability, 
studied ex vivo and in vivo, would allow for photothermal treatments at laser intensities much 
lower than the ones used up to this moment with fluorescent rare earth-based nanomaterials.   
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